Table 1.
Patient ID | Age | Sex | Race | HIV status | Neurocog diagnosis | Plasma VL | CSF VL | CD4 | ARV |
---|---|---|---|---|---|---|---|---|---|
Case 1 | 47 | F | Black | Neg | Normal | NA | NA | NA | NA |
Case 2 | 44 | F | White | Neg | Normal | NA | NA | NA | NA |
Case 3 | 51 | M | White/Hispanic | Neg | Normal | NA | NA | NA | NA |
Case 4 | 49 | M | White | Neg | Normal | NA | NA | NA | NA |
Case 5 | 46 | M | White | Neg | Normal | NA | NA | NA | NA |
Case 6 | 39 | M | Hispanic | Pos | ANI | 570 | <50 | 79 | Yes |
Case 7 | 43 | M | White | Pos | ANI | 249 | 19 | 7 | Yes |
Case 8 | 39 | M | White | Pos | MND | 72,125 | 70 | 1 | Yes |
Case 9 | 33 | M | Hispanic | Pos | MND | 400 | NT | 11 | Yes |
Case 10 | 35 | M | White | Pos | MND/HAD (HIVE) | 2827 | 78 | 211 | Yes |
Case 11 | 37 | M | White | Pos | MND | 178 | 5968 | 85 | Yes |
Case 12 | 31 | M | White | Pos | MND | 483,758 | 148 | 10 | Yes |
Case 13 | 57 | M | Asian | Pos | HAD | 40,133 | 2747 | 299 | Yes |
Case 14 | 30 | F | Hispanic | Neg | Normal | NA | NA | NA | NA |
Case 15 | 48 | F | Hispanic | Neg | Normal | NA | NA | NA | NA |
Case 16 | 50 | M | Hispanic | Neg | Normal | NA | NA | NA | NA |
Case 17 | 56 | F | White | Neg | NA | NA | NA | NA | NA |
Case 18 | 57 | M | Black | Pos | MND | 63,953 | NT | 194 | Yes |
Case 19 | 34 | M | White | Pos | ANI | >750,000 | NT | 9 | Yes |
Case 20 | 46 | M | White | Pos | ANI | <50 | <50 | 233 | Yes |
Case 21 | 45 | M | Hispanic | Pos | MND/HAD | 628 | 376 | 28 | Yes |
Case 22 | 31 | F | Hispanic | Pos | MND/HAD | 744,349 | NT | 4 | Yes |
Case 23 | 55 | F | Black | Pos | ANI | 37,060 | NT | 114 | Yes |
Case 24 | 56 | F | White | Neg | Normal | NA | NA | NA | NA |
Case 25 | 38 | M | White | Neg | ALS | NA | NA | NA | NA |
Case 26 | 53 | F | White | Neg | ALS | NA | NA | NA | NA |
Case 27 | 50 | M | White | Neg | ALS | NA | NA | NA | NA |
Case 28 | 54 | M | White | Neg | ALS | NA | NA | NA | NA |
Case 29 | 57 | F | Hispanic | Neg | ALS | NA | NA | NA | NA |
Data are from last clinic visit. Age at death
NA not applicable, NT not available, HIV Neg seronegative, HIV Pos seropositive, VL viral load, ARV antiretroviral use, ANI asymptomatic neurocognitive impairment, MND minor neurocognitive disorder, HAD HIV-associated dementia, ALS amyotrophic lateral sclerosis